These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 3258458)

  • 1. [Initial experiences with the effect of chronic intermittent electromyostimulation in patients with hyperlipoproteinemias and arterial circulatory disorders].
    Kuklinski B; Gibas P; Köhler H; Grossmann KD; Rühlmann C; Zimmermann R; Voigt H; Reuter W; Duck HJ; Bühnert G
    Z Gesamte Inn Med; 1988 Jan; 43(1):6-11. PubMed ID: 3258458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In vivo effects of high density lipoprotein rich serum fractions (HDLF) in the human. 2. Effect of repeated HDLF infusions on atherogenic risk factors and arteriosclerotic vascular changes in patients with and without hyperlipoproteinemia].
    Kuklinski B; Parfionov AS; Rühlmann C; Zimmermann R; Herrmann W; Richter V; Köhler H; Grossmann KD; Peters HJ; Duck HJ
    Z Gesamte Inn Med; 1989 Jul; 44(14):421-6. PubMed ID: 2683424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of 1 month's treatment with Bezalip on the serum lipids and lipoproteins of patients with different types of hyperlipoproteinemias].
    Kiriakov A; Malamov E; Apostolova Iu; Tsenov I; Tinterova Z
    Vutr Boles; 1983; 22(3):74-81. PubMed ID: 6649587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Oral trapidil treatment of Fontaine stage II arteriosclerotic circulatory disorders of the legs--a double-blind study].
    Voigt H; Reuter W; Hofmann B; Dobberkau A
    Z Gesamte Inn Med; 1990 May; 45(10):283-7. PubMed ID: 2392858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fenofibrate: hypolipaemic activity and safety in long-term treatment. Effects on HDL, LDL, VLDL and apoprotein B in short-term treatment (author's transl)].
    Rouffy J; Sauvanet JP; Chanu B; Bakir R; Goy-Loeper J; Saya C; Pinaroli F
    Nouv Presse Med; 1980 Dec; 9(49):3747-51. PubMed ID: 7208341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of hemosorption on the lipid and lipoprotein composition of the blood plasma].
    Perepelitsa VN
    Vrach Delo; 1990 Jun; (6):32-4. PubMed ID: 2399714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pathologic decrease in lipoprotein lipase activity in relation to the development of hyperlipemias and their significance for coronary heart disease].
    Breier C
    Wien Klin Wochenschr Suppl; 1986; 167():1-16. PubMed ID: 3458343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of short term treatment with simvastatin and atorvastatin on lipids and paraoxonase activity in patients with hyperlipoproteinaemia.
    Paragh G; Törocsik D; Seres I; Harangi M; Illyés L; Balogh Z; Kovács P
    Curr Med Res Opin; 2004 Aug; 20(8):1321-7. PubMed ID: 15324535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of long-term cardiac training on lipids concentration in patients with chronic heart ischemic disease treated with simvastatin].
    Kałka D; Sobieszczańska M; Kopka L; Marciniak W; Zawadzka-Bartczak E; Bak A; Popielewicz-Kautz A; Korzeniowska J; Janczak J; Adamus J
    Pol Merkur Lekarski; 2007 Feb; 22(128):101-6. PubMed ID: 17598652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of dyslipoproteinemia on long-term results of surgical treatment of patients with obliterating atherosclerosis of the lower extremity vessels].
    Sedov VM; Mirchuk KK; Lebedev LV
    Vestn Khir Im I I Grek; 2004; 163(2):50-5. PubMed ID: 15199771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The relation between lipoprotein fractions, sex and IHD in patients with primary hyperlipoproteinemia].
    Hora C; Hanefeld M; Leonhardt W; Jacob F; Haller H
    Z Gesamte Inn Med; 1982 Dec; 37(23):801-4. PubMed ID: 7164523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment possibility of hypercholesterolaemia associated with hypertriglyceridaemia.
    Paragh G; Balogh Z; Boda J; Kovács P; Kárpáti L; Szabó J; Leövey A
    Acta Biol Hung; 1997; 48(3):359-67. PubMed ID: 9406614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of fluvastatin, a new inhibitor of HMG-CoA reductase, and niceritrol on serum lipids, lipoproteins and cholesterol ester transfer activity in primary hypercholesterolemic patients.
    Sasaki J; Yamamoto K; Kobori S; Setoguchi Y; Sato Y; Matsunaga A; Shichiri M; Sakai T; Kono S; Arakawa K
    Int J Clin Pharmacol Ther; 1995 Jul; 33(7):420-6. PubMed ID: 7582401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Parameters of normal and disordered lipid metabolism in the progression and regression of arteriosclerosis].
    Künnert B
    Z Gesamte Inn Med; 1986 Jul; 41(14):394-9. PubMed ID: 3765740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [One year fenofibrate treatment of type II primary hyperlipidaemia. Effects on lipoproteins and biological tolerance (author's transl)].
    Drouin P; Méjean L; Lambert D; Wülfert E; Debry G
    Nouv Presse Med; 1980 Dec; 9(49):3753-7. PubMed ID: 7208342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemorrheologic abnormalities in defined primary dyslipoproteinemias with both high and low atherosclerotic risks.
    Otto C; Ritter MM; Richter WO; Minkenberg R; Schwandt P
    Metabolism; 2001 Feb; 50(2):166-70. PubMed ID: 11229424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Age-related characteristics of the normal blood content of lipids and lipoproteins and in arterial hypertension].
    Tokar AV; Chaialo PP; Rudaia ES; Shevchenko VA
    Vutr Boles; 1983; 22(5):71-6. PubMed ID: 6673337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-HDL cholesterol and apoB in dyslipidaemia.
    Sniderman AD; Hogue JC; Bergeron J; Gagné C; Couture P
    Clin Sci (Lond); 2008 Jan; 114(2):149-55. PubMed ID: 17868037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [MR-Imaging of lower leg muscle perfusion].
    Leppek R; Hoos O; Sattler A; Kohle S; Azzam S; Al Haffar I; Keil B; Ricken P; Klose KJ; Alfke H
    Herz; 2004 Feb; 29(1):32-46. PubMed ID: 14968340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Physical activity in the management of hyperlipoproteinemia].
    Lederer J
    Sem Hop; 1982 May; 58(21):1285-90. PubMed ID: 6287583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.